Macular Degeneration Research

From new drug therapies to micro-telescopic implants, macular degeneration is the subject of vigorous research.

Age Related Macular Degeneration (ARMD) leads to visual impairment and, in some cases, significant central vision loss in millions of people.

Over the last few years, there has been a strong increase in awareness among researchers, the federal government and private pharmaceutical companies as to the magnitude of this problem. This has led to significant economic resources being focused on this problem, resulting in new and innovative therapies.

While new lasering techniques and pharmaceuticals are exciting, there are also significant preventive steps that patients themselves can take in order to reduce the risk of ARMD.

Click on the links to the right to learn more.